Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3708)
All Articles published online
|
Oct 21, 2010 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients. World J Gastroenterol 2010; 16(39): 4938-4943 [PMID: 20954280 DOI: 10.3748/wjg.v16.i39.4938] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i39/4938.htm |
| Number | Citing Articles |
| 1 |
Catherine Johanet, Yannick Chantran, Eric Ballot. Auto-anticorps et pathologies hépatiques. Revue Francophone des Laboratoires 2017; 2017(490): 45 doi: 10.1016/S1773-035X(17)30078-3
|
| 2 |
|
| 3 |
Michele M. Tana, Zakera Shums, Jay Milo, Gary L. Norman, Patrick S. Leung, M. Eric Gershwin, Mazen Noureddin, David E. Kleiner, Xiongce Zhao, Theo Heller, Jay H. Hoofnagle. The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. American Journal of Clinical Pathology 2015; 144(4): 601 doi: 10.1309/AJCPQV4A7QAEEFEV
|
| 4 |
Nikolaos K. Gatselis, Kalliopi Zachou, Gary L. Norman, Stella Gabeta, Panagiotis Papamichalis, George K. Koukoulis, George N. Dalekos. Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease. Autoimmunity 2013; 46(7): 471 doi: 10.3109/08916934.2013.801461
|
| 5 |
Laura Cristoferi, Alessio Gerussi, Pietro Invernizzi. Anti‐gp210 and other anti‐nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know. Liver International 2021; 41(3): 432 doi: 10.1111/liv.14791
|
| 6 |
Eirini I Rigopoulou, Dimitrios P Bogdanos. Role of autoantibodies in the clinical management of primary biliary cholangitis. World Journal of Gastroenterology 2023; 29(12): 1795-1810 doi: 10.3748/wjg.v29.i12.1795
|
| 7 |
Alessandro Granito, Paolo Muratori, Chiara Quarneti, Georgios Pappas, Ronny Cicola, Luigi Muratori. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Review of Molecular Diagnostics 2012; 12(1): 65 doi: 10.1586/erm.11.82
|
| 8 |
Debashis Haldar, Ashnila Janmohamed, Tim Plant, Matthew Davidson, Hannah Norman, Emily Russell, Olivia Serevina, Kenneth Chung, Kashif Qamar, Bridget Gunson, Bettina Hansen, Alex Richter, Palak J. Trivedi, Gideon M. Hirschfield. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver International 2021; 41(3): 535 doi: 10.1111/liv.14688
|
| 9 |
Cristiane Kayser, Lívia Almeida Dutra, Edgard Torres dos Reis-Neto, Charlles Heldan de Moura Castro, Marvin J. Fritzler, Luis Eduardo C. Andrade. The Role of Autoantibody Testing in Modern Personalized Medicine. Clinical Reviews in Allergy & Immunology 2022; 63(2): 251 doi: 10.1007/s12016-021-08918-6
|
| 10 |
Elias Kouroumalis, George Notas. Primary biliary cirrhosis: From bench to bedside. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(3): 32-58 doi: 10.4292/wjgpt.v6.i3.32
|
| 11 |
Alicja Bauer, Andrzej Habior, Damian Gawel. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines 2022; 10(4): 801 doi: 10.3390/biomedicines10040801
|
| 12 |
Yannick Chantran, Eric Ballot, Catherine Johanet. Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): 256 doi: 10.1016/j.clinre.2013.10.008
|
| 13 |
Marcial Sebode, Christina Weiler-Normann, Timur Liwinski, Christoph Schramm. Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00609
|
| 14 |
Carolina Duarte-Rey, Dimitrios Bogdanos, Chen-Yen Yang, Krista Roberts, Patrick S.C. Leung, Juan-Manuel Anaya, Howard J. Worman, M. Eric Gershwin. Primary biliary cirrhosis and the nuclear pore complex. Autoimmunity Reviews 2012; 11(12): 898 doi: 10.1016/j.autrev.2012.03.005
|
| 15 |
Ourania Sfakianaki, Maria Tzardi, Argyro Voumvouraki, Aikaterini Afgoustaki, Meri Koulentaki, Elias Kouroumalis. Presence of disease specific autoantibodies against liver sinusoidal cells in primary biliary cirrhosis. World Journal of Hepatology 2013; 5(10): 568-576 doi: 10.4254/wjh.v5.i10.568
|
| 16 |
David M. Chascsa, Keith D. Lindor. Antimitochondrial Antibody–Negative Primary Biliary Cholangitis. Clinics in Liver Disease 2018; 22(3): 589 doi: 10.1016/j.cld.2018.03.009
|
| 17 |
Anna Reig, Gary L. Norman, Mila Garcia, Zakera Shums, Silvia Ruiz-Gaspà, Chelsea Bentow, Michael Mahler, Maria A. Romera, Odette Vinas, Albert Pares. Novel Anti–Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis. American Journal of Gastroenterology 2020; 115(10): 1634 doi: 10.14309/ajg.0000000000000690
|